All In Biotech

Drug Trial Radar · NCT00828412

Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis

A Randomized, Investigator-Blind, Six-Week, Parallel Group, Multicenter Pilot Study to Compare the Safety and Efficacy of EpiCeram Skin Barrier Emulsion and Desonide Cream 0.05% in the Twice Daily Treatment of Pediatric Subjects With Moderate Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Jan 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Mar 2009

Primary completion

Aug 2009

Study completion Aug 2009

Sponsor

Lead sponsor
Promius Pharma, LLCIndustry
Sponsor type
Industry
First posted
Jan 26, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
All sexes, from 3 months, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.

Conditions

  • Atopic Dermatitis

Interventions

  • EpiCeram Skin Barrier EmulsionDevice

    topical cream, twice daily, 6 weeks

  • Desonide Cream 0.05%Drug

    topical cream, twice daily, 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Three Item Severity ScoreTime frame: Baseline to 6 weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • National Jewish Health

    Denver, Colorado

  • Northwestern University

    Chicago, Illinois

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina

  • Dermatology Research Associates

    Cincinnati, Ohio

  • University of Texas

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.